Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Gap Up – Still a Buy?

Shares of Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) gapped up before the market opened on Friday . The stock had previously closed at $17.94, but opened at $18.91. Telix Pharmaceuticals Limited American Depositary Shares shares last traded at $18.58, with a volume of 1,896 shares.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on TLX shares. UBS Group increased their target price on Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the company a “buy” rating in a research note on Monday, January 27th. William Blair reiterated an “outperform” rating on shares of Telix Pharmaceuticals Limited American Depositary Shares in a research note on Wednesday, March 12th.

Telix Pharmaceuticals Limited American Depositary Shares Price Performance

The stock’s fifty day moving average price is $17.17.

Telix Pharmaceuticals Limited American Depositary Shares Company Profile

Telix Pharmaceuticals Limited. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.